Average Co-Inventor Count = 7.39
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck + Co., Inc. (9 from 4,770 patents)
2. Merck Sharp + Dohme Corp. (9 from 2,405 patents)
3. Ra Pharmaceuticals, Inc. (2 from 28 patents)
4. Other (1 from 832,966 patents)
19 patents:
1. 12012468 - Cyclic polypeptides for PCSK9 inhibition
2. 11530244 - Cyclic polypeptides for PCSK9 inhibition
3. 11413292 - Tricyclic heterocycle compounds useful as HIV integrase inhibitors
4. 10221186 - Spirocyclic heterocyclic compounds useful as HIV integrase inhibitors
5. 10150780 - Spirocyclic heterocycle compounds useful as HIV integrase inhibitors
6. 9951079 - Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
7. 9714243 - 4-pyridinonetriazine derivatives as HIV integrase inhibitors
8. 9707234 - Spirocyclic hetercycle compounds useful as HIV integrase inhibitors
9. 8513234 - HIV integrase inhibitors
10. 7820680 - HIV integrase inhibitors
11. 7538112 - HIV integrase inhibitors
12. 7435735 - Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
13. 7323460 - N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors
14. 6921759 - Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors
15. 6380249 - HIV integrase inhibitors